Position in OCGN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$141,000
+$135,599 QoQ
Shares Held
77,901
+1847.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,278,082,982 across 390 Biotechnology names. OCGN ranks #192 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,067 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,105 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,231 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in OCGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $141,000 | 77,901 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $5,401 | 4,001 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,744 | 1,070 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $11,152 | 11,497 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $103,963 | 147,257 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $114,127 | 141,773 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $86,142 | 86,838 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $139,578 | 90,051 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $11,537 | 7,035 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $6,240 | 10,853 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $4,273 | 10,684 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,516 | 10,161 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $43,094 | 50,521 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $11,050 | 8,500 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $44,608 | 25,061 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $65,861 | 29,014 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $435,447 | 131,954 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $851,404 | 187,122 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,153,774 | 160,693 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $122,183 | 15,216 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $40,188 | 5,919 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $10,165 | 5,555 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $256 | 828 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $47 | 216 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $60 | 214 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||